Breakthrough ALS study launches as drug aims to slow disease progression

The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.


3 w.
Science
ID: 828222353062015271


Similar News expand_more


Science
Science
Science
Science
Science
Science
Technology
Science
Science
Technology
Science
Economics
Science
Science
Science
Economics
Science
Science
Technology
Science
Economics
Crime
Science
Science
Science
Economics
Science
Crime
Science
Science
Science
Science
Science
Science
Science
Crime
Science
Science
Science
Technology
Science
Science
Technology
Technology
Science
Science
Technology
Science
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down